Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14 […]Read More… from Early treatment intensification with R-ICE and 90Y-ibritumomab tiuxetan (Zevalin)-BEAM stem cell transplantation in patients with high-risk diffuse large B-cell lymphoma patients and positive interim PET after 4 cycles of R-CHOP-14
A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes. […]Read More… from A cryptic deletion in 5q31.2 provides further evidence for a minimally deleted region in myelodysplastic syndromes.
Novel endogenous type D retroviral particles expressed at high levels in a SCID mouse thymic lymphoma. […]Read More… from Novel endogenous type D retroviral particles expressed at high levels in a SCID mouse thymic lymphoma.
Viable bone marrow stromal cells are required for the in vitro survival of B-cell precursor acute lymphoblastic leukemic cells. […]Read More… from Viable bone marrow stromal cells are required for the in vitro survival of B-cell precursor acute lymphoblastic leukemic cells.
Flow cytometric analysis of intercellular adhesion between B-cell precursor acute lymphoblastic leukemic cells and bone marrow stromal cells. […]Read More… from Flow cytometric analysis of intercellular adhesion between B-cell precursor acute lymphoblastic leukemic cells and bone marrow stromal cells.
Human bone marrow stromal cell contact and soluble factors have different effects on the survival and proliferation of paediatric B-lineage acute lymphoblastic leukaemic blasts. […]Read More… from Human bone marrow stromal cell contact and soluble factors have different effects on the survival and proliferation of paediatric B-lineage acute lymphoblastic leukaemic blasts.
Measurement of the growth parameters of precursor B-acute lymphoblastic leukaemic cells in co-culture with bone marrow stromal cells; detection of two cd10 positive populations with different proliferative capacities and survival. […]Read More… from Measurement of the growth parameters of precursor B-acute lymphoblastic leukaemic cells in co-culture with bone marrow stromal cells; detection of two cd10 positive populations with different proliferative capacities and survival.
A novel approach to the measurement of different in vitro leukaemic cell growth parameters: the use of PKH GL fluorescent probes. […]Read More… from A novel approach to the measurement of different in vitro leukaemic cell growth parameters: the use of PKH GL fluorescent probes.
Activated killer cell lymphoma: an erythrophagocytic syndrome simulating histiocytic medullary histiocytosis. […]Read More… from Activated killer cell lymphoma: an erythrophagocytic syndrome simulating histiocytic medullary histiocytosis.
A human complement-fixing monoclonal anti-human lymphocyte antibody of rat origin. […]Read More… from A human complement-fixing monoclonal anti-human lymphocyte antibody of rat origin.
Studies by radioiodination of normal adult, fetal and leukemic cell membranes. […]Read More… from Studies by radioiodination of normal adult, fetal and leukemic cell membranes.
Ceramides that mediate apoptosis reduce glucose uptake and transporter affinity for glucose in human leukaemic cell lines but not in neutrophils […]Read More… from Ceramides that mediate apoptosis reduce glucose uptake and transporter affinity for glucose in human leukaemic cell lines but not in neutrophils
Biochemical effect of three different inhibitors of purine/pyrimidine metabolism on differentiation in HL60 cells. […]Read More… from Biochemical effect of three different inhibitors of purine/pyrimidine metabolism on differentiation in HL60 cells.
An emerging role for immune regulatory subsets in chronic lymphocytic leukaemia. […]Read More… from An emerging role for immune regulatory subsets in chronic lymphocytic leukaemia.
Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia […]Read More… from Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia
Haematologic MalignanciesHaematologic Malignancies
Haematologic Malignancies